MADISON, WI. - Quintessence Biosciences, Inc., a biotechnology company developing pharmaceutical products for use in research, has finalized a three million dollar financing deal. The majority of the funding, $2.3 million, was received from individual investors, and the remainder was borrowed from the Madison Development Corporation, Wisconsin Department of Commerce, and m2 Lease Funds, a private ......Full article >>>
as received, it has been placed in the exciting position of entering the marketplace with highly sought new tools for protein research.
One of the projects of Quintessence Biosciences is the formulation of multivalent drugs. Multivalent drugs are a new class of medications able to attach to pathogens with several binding sites, enabling them to be precise enough tools to treat a wide va......Full article >>>
ged cartilage or ligaments. Also, collagen is also required for the healing of wounds; products using synthetic collagen could assist in wound treatment.
"Its worth noting that both Quintessence and Nutra-Park, which also announced a round of financing last Thursday, were presenters at the November 2002 Wisconsin Life Sciences Venture Conference sponsored by the Wisconsin Technology Coun......Full article >>>
Source:wistechnology.com By Jamie Lyn Hofmeister 05/28/03Related biology technology :1
. Quintessence Biosciences advances cancer drug2
. Quintessence Biosciences names new president3
. Quintessence cancer treatment chosen for clinical studies4
. Quintessence division to develop drug tests with NIH grant5
. Quintessence Biosciences forms cancer therapeutic advisory board6
. nPoint Secures Second Round of Funding7
. Financing life science: The ongoing saga8
. Financing of biotech companies so far in 2005: A Midwest odyssey9
. Seed-Stage Venture Financing